Live Breaking News & Updates on First Cell Based Gene Therapies Casgevy

The FDA approved Vertex/CRISPR Therapeutics’ Casgevy® and Bluebird Bio’s Lyfgenia®, the first cell-based gene therapies to treat sickle cell disease… ....

United States , United Kingdom , Bio Lyfgenia , Astrazeneca Merck Lynparza , Samsung Bioepi Byooviz , Genentech Lucentis , Genentech Avastin , Polpharma Biologics , Roche Susvimo , Bristol Myers Squibb , Merck Lynparza , Sandoz Bio Thera Avzivi , Health Canada , European Medicines Agency , National Institute For Health , First Cell Based Gene Therapies Casgevy , Treat Sickle Cell , Bluebird Bio , Approval Alert , Bevacizumab Biosimilar , High Grade Ovarian , Fallopian Tube , National Institute , Care Excellence , Middle East , North Africa ,